Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pharmabranche: Novo Nordisk stoppt zwei weitere Studien zu Herzmedikament

Das Herzmedikament Ziltivekimab des dänischen Pharmariesen zeigt in Studien bislang nicht die gewünschte Wirkung. Die Aktie reagiert auf den erneuten Rückschlag.

Pharmabranche: Novo Nordisk stoppt zwei weitere Studien zu Herzmedikament

We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.

Read the original at handelsblatt.com →

More in Health & Medicine

Nigeria: Diphtheria - Jos North Steps Up Surveillance As Plateau Intensifies Response

[Premium Times] The intervention comes amid reported diphtheria cases in Jos North, where 117 suspected cases and 15 deaths had been recorded as of 1 September, according to health authorities

  • Jos North Local Government intensifies diphtheria surveillance with motorcycles.
  • Plateau State closes schools due to diphtheria cases in multiple areas.
  • Authorities urge vaccination and prompt medical attention for symptoms.

Nigeria: Donor Cuts, Govt Inaction Negatively Impact HIV Patients in Rivers, Akwa Ibom (3)

[Premium Times] Conclusion of PREMIUM TIMES' three-part series: As donor support declines, laws meant to guarantee political leadership, funding and protection for people living with HIV remain weakly…

  • Donor funding cuts impact HIV patients in Rivers and Akwa Ibom states.
  • Weak government action hinders HIV response despite laws.
  • No records found of statutory mechanisms functioning during transition.

More from Monday 7 September →